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Susceptibility to Various Antimicrobiai 
Agents and Tolerance to Methicillin of 
Staphylococcus aureus Isolates from 
Cystic Fibrosis Patients 
Pseudomonas eruginosa, Staphylococcus aureus 
and Haemophilus influenzae are the pathogenic 
bacterial species most frequently detected in the 
respiratory tract of patients with cystic fibrosis 
(CF). To minimize progression of pulmonary 
.destruction, acute exacerbations in CF demand 
intensive antimicrobial chemotherapy (1). Since 
Persistent colonization and infection with identi- 
cal types of Staphylococclz~ aureus have been 
described (2), frequent and prolonged treatment 
With various antimicrobial gents may influence 
resistance and tolerance in strains. Tolerance to 
Penicillin has been proposed as one possible ex- 
planation for the poor response of some strep- 
tococcal infections to penicillin therapy (2). In 
this study we tested the activity of various anti- 
.microbial agents against Staphylococcus aureus 
tsolates from patients with CF. In addition 
tolerance to methiciltin in the isolates was inves- 
tigated. 
Fifty.two isolates of Staphylococcus aureus were 
recovered from sputum of 52 patients with CE 
The strains were identified biochemically by 
means of the API-STAPH identification system 
and Stored at -70 °C until tested. Additional tests 
3ncluded a slide coagulase test, a catalase test and 
mannitol fermentation. 
13erection of beta-lactamases was performed as 
follows. Nitrocefin (0.1 ml) was placed in a micro- 
dilution well and a bacterial suspension yielding 
107 cfu/ml was added. Production of beta-Iac- 
tamases was established if the solution turned a 
deep red within ten minutes. 
Antirnicrobial gents were obtained as a standard 
laboratory powder from the manufacturers and 
StOred and handled as recommended. MICs were 
determined by an agar dilution technique. Freshly 
Prepared serial twofold dilutions of antibiotic 
Were incorporated in Diagnostic Sensitivity Test 
agar (Oxoid, UK) Agar supplemented with 4% 
,*aCl was Used to define methicillin susceptibility 
3)~: Final concentrations ranged from 0.006 to 
.,.u mg/l (for penicillin up to 410 mg/1). Plates 
Were inoculated with a multipoint inoculator, 
Which delivered a final inoculum of 104 cfu per 
o p°t (1 ~1 of liquid) from overnight Mueller-Hin- 
.a broth (Oxoid) cultures adjusted to 108 cfu/ml 
~mg a barium sulphate standard and diluted 10 d. 
~no~ulated plates were incubated at 35 °C for 24 
rs. The MIC was defined as the lowest con- 
centration of antimicrobial gent which inhibited 
visible growth. Staphylococcus aureus strains 
ATCC 25923 and ATCC 29213 were included as 
control organisms in all sets of inoculations, and 
the MICs were consistent with established values 
within one twofold dilution. 
Tolerance to methicillin was determined using the 
gradient technique of Kim and Anthony (4). 
Briefly, 40 ml of Mueller-Hinton agar (Difco) sup- 
plemented with 20 mg/l methicillin was allowed to 
gel in a 15 x 15 x 1.5 cm square petri dish which was 
placed at an angle to form a wedge. Once cooled, 
60 ml of the same agar, bat without antibiotics, 
was overlaid, and allowed to set on a level surface 
resulting in graduated concentrations ominally 
ranging from 0 to 20 mg/l. Late-logarithmic cul- 
tures were prepared and applied undiluted using 
cotton wool swabs. Up to six strains together with 
a non-tolerant and a tolerant control were inocu- 
lated as parallel streaks beginning at the lowest 
concemration along the axis of the gradient. As 
expected, there was no apparent growth after 24 
hours and an impression of the surface was made 
using a sterile velvet pad which was applied to a 
methicillin-free plate. This was incubated for 24 
hours and the result growth was compared with 
that of the controls. Tolerance was defined as any 
growth which occurred beyond that of the non- 
tolerant control along the line of inoculation. 
The results are summarized in Table 1 and Table 
2. Fourty-nine isolates prod uced beta-lactamases. 
The penicillin and methicillin MIC modes for 
these strains were 12.8 and 1.6 mg/l respectively. 
Methicillin resistant strains of Staphylococcus 
aureus were not found. On a weight basis ira: 
ipenem and rifampicin were the most active of the 
agents tested, inhibiting 100% of the isolates at 
0.025 mg/l and 0.05 mg/l respectively. At clinically 
attainable serum concentrations flucloxacillin, 
cefamandole and cefuroxime had similar activity. 
With the exception of erythromycin, clindamycin 
and fusidic acid, MIC ranges were within one (im- 
ipenem, vancomycin) tofour (ciprofloxacin, gen- 
tamicin) twofold dilutions. However, it should be 
noted that the wider MIC ranges observed for 
erythromycin, clindamycin and fusidic acid were 
due to a single isolate. The gentamicin MIC for 
the 52 isolates was 0.4 mg/l or less. In general, 
MICs of the drugs tested were within the ther- 
apeutic range. Six strains (11.2%) appeared to be 
tolerant to methicillin. The proportion of tolerant 
strains identified in this study, i.e. 11.2%, is similar 
to that of 12.5% reported by Goessens et al. (5) in 
non-CF populations of Staphylococcus aureus. 
We therefore conclude that frequent therapy in 
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Table 1: In vitro activity of penicillin and methicillin against 52 isolates of Staphylococcus aureus ob- 
tained from 52 patients with cystic fibrosis. 
Production of 
beta-lactamases 
Penicillin MIC (mg/l) Methicillin MIC (mg/1) 
Range Mode Range Mode 
Negative (n = 3) 0.05 0.05 1.6- 3.2 1.6 
Positive (n = 49) 0.8-102.4 12.8 0.8-12.8 1.6 
Table 2: In vitro activity of various antimicrobial agents against 52 isolates of Staphylococcus aureus obtained from 52 
patients with cystic fibrosis. 
Antimicrobial Cumulative percentage of isolates inhibited at given concentration (mg/l) 
agent 
<_.0.006 0.012 0.025 0.05 0.1 0.2 0.4 0.8 1.6 3.2 >6.4 
Flueloxacillin 13 73 100 
Imipenem 60 100 
Cefamandole 23 94 100 
Cefuroxime 6 27 100 
Gentamicin 2 2 10 96 100 
Erythromycin 2 10 96 96 96 98 98 100 
Clindamycin 2 12 96 98 98 98 98 98 100 
Rifampicin 8 87 100 
Fusidic acid 46 98 98 98 98 98 98 100 
Vancomycin 10 100 
Teicoplanin 4 13 100 
Ciprofloxacin 2 4 87 100 
Fleroxacin 6 98 100 
CF does not result in higher tolerance. Whether 
tolerance plays a role or not in the clinical out- 
come in CF has never been determined. Using the 
simple and reliable method described here it 
should now be possible to determine this. 
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